BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31807070)

  • 21. Limited Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratios in Elderly Patients with Multiple Myeloma.
    Wang J; Wang J; Sun C; Xia J; Zhou X; Guo HF
    Clin Lab; 2018 Apr; 64(4):507-513. PubMed ID: 29739072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of the combination of preoperative red cell distribution width and platelet distribution width in patients with gastric cancer.
    Saito H; Shimizu S; Shishido Y; Miyatani K; Matsunaga T; Fujiwara Y
    BMC Cancer; 2021 Dec; 21(1):1317. PubMed ID: 34879841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Influence of CONUT Score on the Prognosis of Patients with Multiple Myeloma].
    Li YQ; Wang Y; Song Y; Han Y; Li JJ; Yue LL; Zeng PY; Wu CY; Chai Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):781-786. PubMed ID: 34105472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
    García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
    PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.
    Bao Y; Yang M; Jin C; Hou S; Shi B; Shi J; Lin N
    World Neurosurg; 2018 Nov; 119():e710-e716. PubMed ID: 30092479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer.
    Li Z; Hong N; Robertson M; Wang C; Jiang G
    Sci Rep; 2017 Feb; 7():43001. PubMed ID: 28223716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
    Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
    PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Red cell distribution width, neutrophil lymphocyte ratio and interleukin 10 are good prognostic markers in multiple myeloma.
    Seyam MM; Esheba NE; Eid MA; Gabr MA
    Biomedicine (Taipei); 2023; 13(2):34-39. PubMed ID: 37937298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory parameters as predictors of prognosis in uterine cervical neoplasia.
    Lima PSV; Mantoani PTS; Murta EFC; Nomelini RS
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():391-396. PubMed ID: 33279808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Red Blood Cell Distribution Width to Platelet Ratio is an Independent Poor Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.
    Li M; Bai Y; Sun X; Wang H; Li W; Xiao X; Chen Y; Sun K
    Discov Med; 2023 Apr; 35(175):157-167. PubMed ID: 37105925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value of the revised international staging system for newly diagnosed multiple myeloma patients].
    Lu J; Du J; Fu WJ; He HY; Li L; Li R; Zhou LL; Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):475-479. PubMed ID: 28655089
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognostic Value of Red Blood Cell Distribution Width in Senile Potients with Non-trans planted Multiple Myeloma].
    Sun C; Ye JN; Wang H; Zhu JW; Zhou X; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):115-122. PubMed ID: 30738457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Mean Platelet Volume/platelet count Ratio and Neutrophil to Lymphocyte Ratio on the risk of Febrile Seizure.
    Liu Z; Li X; Zhang M; Huang X; Bai J; Pan Z; Lin X; Yu D; Zeng H; Wan R; Ye X
    Sci Rep; 2018 Oct; 8(1):15123. PubMed ID: 30310107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis.
    Lu J; Lu J; Liu A; Fu W; Du J; Huang X; Chen W; Hou J
    Biomed Res Int; 2015; 2015():856704. PubMed ID: 26640799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents.
    Shang Y; Jin Y; Liu H; Ding L; Tong X; Tu H; Zang L; Lin C; Hu J; Zhou F
    Hematol Oncol; 2022 Apr; 40(2):212-222. PubMed ID: 34860428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of absolute lymphocyte/monocyte ratio, red cell distribution width and neutrophil/ lymphocyte ratio in diffuse large B-cell lymphoma patients.
    Hasan KM; Elmeshhedany AY
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):61-68. PubMed ID: 34933732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Red Blood Cell Distribution Width and Multiple Myeloma in a Guangxi Population: a Retrospective Study.
    Huang C; Wei H; Lan F; Lu Y; Li S; Qin X
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Platelet Count and Mean Platelet Volume and Red Cell Distribution Width Be Used as a Prognostic Factor for Mortality in Intensive Care Unit?
    Duran M; Uludağ Ö
    Cureus; 2020 Nov; 12(11):e11630. PubMed ID: 33376644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens.
    Chim CS; Sim J; Tam S; Tse E; Lie AK; Kwong YL
    Eur J Haematol; 2015 Apr; 94(4):330-5. PubMed ID: 25135740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.